October 6, 2016 / 5:15 AM / a year ago

BRIEF-Galenica appoints new CFO, new management at Vifor Pharma

Oct 6 (Reuters) - Galenica AG :

* New management at Vifor Pharma and new Galenica Group CFO designated

* Stefan Schulze will take over this position from the annual general meeting of Galenica Ltd. in May 2017

* From that date, Felix Burkhard will take over as CFO from Joerg Kneubuehler

* Kneubuehler will in future concentrate fully on his role as CEO of Galenica Santé

* Has designated Stefan Schulze, currently CEO of Vifor Fresenius Medical Care Renal Pharma (VFMCRP), as chief operating officer (COO) and president of executive committee of Vifor Pharma

* The board of directors has also appointed Felix Burkhard as CFO of the Galenica Group with effect from January 1, 2017

* Previous guidance in respect of 2016 Galenica Group net profit increasing by approximately 10 percent before and after deduction of minority interests on a comparable basis is confirmed

* Guidance in respect of 2016 Galenica Group net profit decreasing by approximately 90 million Swiss francs ($92.31 million) as a result of the investment required to ramp-up sales of Veltassa is unchanged Source text - bit.ly/2dujKKr Further company coverage: ($1 = 0.9750 Swiss francs) (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below